Efficacy and mechanism of traditional Chinese medicine in relieving antibiotic-resistant bacterial diarrhea in children: study protocol for a randomized controlled trial

Abstract

Background Bacterial infection is an important cause of diarrhea in children, potentially leading to malnutrition, growth and development disorders, and even death. Antibiotic abuse and resistance are widespread problems worldwide, especially in China. We therefore designed a study to evaluate the clinical efficacy and mechanism of traditional Chinese medicine in alleviating the effects of antibiotic resistance in childhood bacterial diarrhea and enhancing the sensitivity of pathogenic bacteria to antibiotics. Methods This randomized, double-blind, placebo-controlled clinical trial has completed ChiCTR registration. The trial will randomly divide 120 children who meet the inclusion criteria into three groups: experimental group 1 (basic treatment + Gegen Qinlian decoction granules + Erbai drink placebo), experimental group 2 (basic treatment + Erbai drink granules + Gegen Qinlian decoction placebo), and control group (basic treatment + Gegen Qinlian decoction placebo + Erbai drink placebo). The main efficacy indicators will be antibiotic use rate and clinical cure rate, and the secondary efficacy indicators will be time to antibiotic intervention, effective rate, and course of treatment determined after 5 days. The following physical and chemical indicators will be measured: routine blood parameters, procalcitonin, C-reactive protein, electrocardiogram, liver and kidney function, electrolytes, routine urinalysis, routine stool analysis, and stool culture (including drug sensitivity). Discussion The results of this study may provide an objective clinical basis for the use of traditional Chinese medicine in managing antibiotic-resistant bacterial diarrhea in children, formulating relevant guidelines, and demonstrating the use of traditional Chinese medicine for reducing the use of antibiotics. Trial registration Chinese Clinical Trial Registry ChiCTR1900027915. Last refreshed on December 4, 2019.

China’s innovation and research contribution to combating neglected diseases: a secondary analysis of China’s public research data

“…Research and Development activities lag far behind "the big three," disproportionate to their importance for global health. Some Chinese patent medicines have shown research progress in relieving chronic diarrhea and antibiotic-resistant bacterial diarrhea [20]. This presents a promising funding opportunity for China to increase R&D support for global ND priorities.…”

Network pharmacology and in vivo and in vitro experiments to determine the mechanism behind the effects of Jiawei Yanghe decoction via TLR4/Myd88/NF-κB against mastitis

“…In this context, Chinese medicine has played a unique role in treating inflammatory diseases. By reversing bacterial resistance, the synergistic effect of TCM and antibiotics can enhance anti-inflammatory and antibacterial effects, thereby reducing the need for antibiotics [ [40] , [41] , [42] ]. The TCM mode of action in mastitis treatment may involve directly killing the pathogen directly, regulating systemic functions, and reshaping the imbalance, thus exerting an irreversible anti-inflammatory effect.…”

Efficacy and Safety of Gegen Qinlian Decoction for Pediatric Diarrhea: A Systematic Review and Meta-Analysis

“…At present, most international guidelines recommend the application of oral rehydration salts for treatment. In the case of bacterial infections, antibiotics are also recommended [ 15 – 17 ]; however, the irrational use of antibiotics often leads to an imbalance in the intestinal flora and antibiotic resistance in children [ 18 , 19 ]. Antimicrobial resistance is a major cause of clinical antimicrobial therapeutic failure [ 20 ].…”